As the emphasis to move patients from an inpatient setting to their homes for less expensive therapies surfaced, home infusion therapy providers emerged and the industry continues to grow exponentially each year. The complexity of the high-tech services and drugs administered at home has also contributed to billing and reimbursement challenges between home infusion providers and payers. EquiClaim, an Emdeon company, recognized the high incidence of billing and reimbursement errors and developed the most comprehensive post-payment review and recovery program in the industry, allowing payers to regulate the reimbursement of these complex agreements.